UNIVERSITY OF UTAH

Patent Owner

Follow Compare Add to Portfolio 8Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 20388
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13628
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12982
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 99124
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9871
 
 
 
C07K PEPTIDES 8552
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 7832
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 64360
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 5838
 
 
 
C07D HETEROCYCLIC COMPOUNDS 34119

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0120,078 THERAPEUTIC ULTRASOUND BREAST TREATMENTJun 15, 15May 04, 17[A61N, A61B]
2017/0122,893 INTERFACIAL NANOFIBRIL COMPOSITE FOR SELECTIVE ALKANE VAPOR DETECTIONNov 03, 16May 04, 17[G01N]
2017/0113,975 METHODS OF SINTERING DENSE ZETA-PHASE TANTALUM CARBIDEJun 17, 15Apr 27, 17[C04B]
2017/0110,678 DUAL-GATE CHEMICAL FIELD EFFECT TRANSISTOR SENSORJul 23, 15Apr 20, 17[H01L, G01N]
2017/0100,375 COMPOSITIONS AND METHODS COMPRISING 2-(ACYLAMINO)IMIDAZOLESSep 16, 16Apr 13, 17[A61K]
2017/0103,187 DISEASE THERAPY GAME TECHNOLOGYDec 22, 16Apr 13, 17[G06F, A63F]
2017/0095,501 PHARMACEUTICAL COMPOSITIONS COMPOSED OF LOW MOLECULAR WEIGHT SULFATED HYALURONANDec 16, 16Apr 06, 17[A61K]
2017/0089,908 SYSTEMS AND METHODS FOR LABEL-FREE DETECTION OF ANALYTESSep 29, 16Mar 30, 17[G01N]
2017/0067,015 ELECTROPHYSIOLOGICAL RECORDING SYSTEM AND METHODS OF USING SAMESep 16, 16Mar 09, 17[C12N]
2017/0058,047 METHOD OF DETECTING OCULAR DISEASES AND PATHOLOGIC CONDITIONS AND TREATMENT OF SAMEApr 06, 16Mar 02, 17[C12Q, G01N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9642623 Methods, devices and apparatus for performing a vascular anastomosisApr 15, 11May 09, 17[A61B]
9642795 Intravaginal devices for controlled delivery of lubricantsJan 04, 16May 09, 17[A61M, A61K]
9642857 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitorsJan 04, 16May 09, 17[C07D, C07C, A61K]
9630997 Compositions and methods for peptide expression and purification using a type III secretion systemMay 30, 13Apr 25, 17[C12N, C12P, C07K]
9631239 Method of classifying a breast cancer instrinsic subtypeJun 01, 09Apr 25, 17[C12Q, G06F, G06G]
9616540 System and method for dispensing a minimum quantity of cutting fluidFeb 08, 12Apr 11, 17[B23Q]
9617316 Mutant sodium channel Nav1.7 and methods related theretoAug 14, 13Apr 11, 17[C12N, C07H, A01K, C12Q, C07K]
9606277 Apparatus and methods for reducing frequency or severity of photophobic responses or modulating circadian cyclesJan 17, 12Mar 28, 17[A61N, G02C, G02B, A61M, A61B]
9599524 High-resolution flexible tactile imager system based on floating comb electrodeApr 04, 14Mar 21, 17[G01L]
9599628 Small molecule-dependent split aptamer ligationMar 08, 16Mar 21, 17[C12N, C12Q, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0109,431 Development Of Natural Killer Cells And Functional Natural Killer Cell LinesABANAug 24, 15Apr 21, 16[G01N]
2015/0322,120 SODIUM CHANNEL SENSITIVE CONOPEPTIDES AND ANALOGS, INCLUDING COMPOSITIONS AND METHODS THEREOFABANApr 17, 13Nov 12, 15[C07K]
2015/0320,675 Modified Release Osmotic Pump for PH-Responsive Drug DeliveryABANJan 17, 14Nov 12, 15[A61K]
2015/0194,473 Device Comprising Deuterated Organic InterlayerABANDec 11, 14Jul 09, 15[H01L]
2015/0182,601 COMPOSITIONS AND METHODS FOR SELECTIVELY PRODUCING SIRNAABANJul 28, 14Jul 02, 15[A61K]
2015/0152,382 PURE POPULATIONS OF ASTROCYTE RESTRICTED PRECURSOR CELLS AND METHODS FOR ISOLATION AND USE THEREOFABANJan 20, 15Jun 04, 15[C12N, G01N, A61K]
2015/0148,251 AUTISM ASSOCIATED GENETIC MARKERSABANNov 10, 14May 28, 15[C12Q]
2015/0133,411 COMPOUNDS WITH TRPV4 ACTIVITY, COMPOSITIONS AND ASSOCIATED METHODS THEREOFABANMar 15, 13May 14, 15[C07D, A61K]
2015/0118,760 FLUORESCENT SENSING OF VAPORS USING TUBULAR NANOFIBRIL MATERIALSABANAug 08, 12Apr 30, 15[G01N]
2015/0099,790 COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITYABANMay 08, 13Apr 09, 15[C12N, C12Q, A61K]
2015/0100,046 INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODSABANOct 09, 13Apr 09, 15[A61F]
2015/0061,832 DIRECTLY OBSERVED THEARPY USING MOBILE TECHNOLOGYABANSep 05, 14Mar 05, 15[A61B, G07C, G06K]
2015/0024,399 MOLECULAR DIAGNOSIS AND TYPING OF LUNG CANCER VARIANTSABANJul 18, 14Jan 22, 15[C12Q, G01N]
2014/0358,116 METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMORABANAug 18, 14Dec 04, 14[A61N, A61K]
2014/0346,948 MICRO-PLASMA FIELD EFFECT TRANSISTORSABANJan 29, 14Nov 27, 14[H01J]
2014/0350,218 ALPHA-CONOTOXIN PEPTIDESABANApr 15, 14Nov 27, 14[C07K]
2014/0341,803 STABLE NANOEMULSIONS USEFUL IN THE TREATMENT OF CANCERABANMay 14, 14Nov 20, 14[A61K]
2014/0342,926 Methods for Assessing Risk for Cardiac Dysrythmia in a Human SubjectABANFeb 11, 14Nov 20, 14[C12Q]
2014/0323,392 METHODS AND COMPOSITIONS RELATED TO INHIBITION OF VIRAL ENTRYABANMar 28, 12Oct 30, 14[A61K, C07K]
8857117 Anchoring, splicing and tensioning elongated reinforcement membersWithdrawnOct 01, 10Oct 14, 14[E04C, E01D, E04B, E04G]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.